Cogent Biosciences (COGT) Asset Utilization Ratio (2018 - 2020)
Cogent Biosciences (COGT) recorded quarterly Asset Utilization Ratio of 0.04 in Q4 2020, down 85.13% quarter-over-quarter from 0.27 in Q3 2020, and down 90.39% on a YoY basis from 0.42 in Q1 2020.
Cogent Biosciences (COGT) Asset Utilization Ratio (2018 - 2020) Analysis & Trends
Cogent Biosciences' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.04 for Q4 2020.
- In Q4 2020, Asset Utilization Ratio fell 90.39% year-over-year to 0.04; the TTM figure through Dec 2020 stood at 0.04 (down 90.39% YoY), while the FY2020 annual figure was 0.05, down 84.23% from the prior year.
- Asset Utilization Ratio was 0.04 for Q4 2020 at Cogent Biosciences, down from 0.27 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.68 in Q2 2020 to a low of 0.04 in Q4 2020.
- Historically, Asset Utilization Ratio has averaged 0.25 across 3 years, with a median of 0.17 in 2019.
- Biggest YoY gain for Asset Utilization Ratio was 374.14% in 2020; the steepest drop was 90.39% in 2020.
- A 3-year view of Asset Utilization Ratio shows it stood at 0.11 in 2018, then surged by 289.25% to 0.42 in 2019, then sank by 90.39% to 0.04 in 2020.
- The last three Asset Utilization Ratio figures came in at 0.04 (Q4 2020), 0.27 (Q3 2020), and 0.68 (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 0.55 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Cogent Biosciences | 5.09 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.04 |
| Sep 30, 2020 | 0.27 |
| Jun 30, 2020 | 0.68 |
| Mar 31, 2020 | 0.60 |
| Dec 31, 2019 | 0.42 |
| Sep 30, 2019 | 0.17 |
| Jun 30, 2019 | 0.16 |
| Mar 31, 2019 | 0.13 |
| Dec 31, 2018 | 0.11 |
| Sep 30, 2018 | 0.08 |
| Jun 30, 2018 | 0.11 |
| Mar 31, 2018 | 0.19 |